Publications by authors named "Victoria Daventure"

Claim this Profile
R
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptides.
Alejandra Reyes-Ruiz, Sandrine Delignat, Aurélien Azam, Victoria Daventure, Leslie Dourthe

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of therapeutic Fc-fused factor VIII to the neonatal Fc receptor at neutral pH associates with poor half-life extension.
Alejandra Reyes-Ruiz, Sandrine Delignat, Aishwarya Sudam Bhale, Victoria Daventure, Robin V Lacombe

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion Technology.
Victoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi, Alejandra Reyes-Ruiz, Amélia Trecco

Eur J Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitro.
Rohini Sekar, Angelina Mimoun, Melissa Bou-Jaoudeh, Stéphane Loyau, Sandrine Delignat, Victoria Daventure

J Thromb Haemost· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
Melissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, Ivan Peyron, Ladislas Capdevila, Victoria Daventure

J Thromb Haemost· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy.
Angelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, Alejandra Reyes Ruiz

J Thromb Haemost· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice.
Melissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, Jan Astermark, Hervé Lévesque

Haematologica· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance.
Angelina Mimoun, Sandrine Delignat, Ivan Peyron, Victoria Daventure, Maxime Lecerf

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
V Region of IgG Controls the Molecular Properties of the Binding Site for Neonatal Fc Receptor.
Sofia Rossini, Rémi Noé, Victoria Daventure, Maxime Lecerf, Sune Justesen

J Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
Christian Leborgne, Elena Barbon, Jeffrey M Alexander, Hayley Hanby, Sandrine Delignat, Victoria Daventure

Nat Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatic Guanylhydrazones for the Control of Heme-Induced Antibody Polyreactivity.
Nina Božinović, Vladimir Ajdačić, Jelena Lazic, Maxime Lecerf, Victoria Daventure

ACS Omega· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis